EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy and Safety of Guggulu Tablet in Obesity and Rheumatic Disease Activity: An Open-Label, Single-Arm Clinical Trial

Dnyaneshwar Bhagwan Mote, Sandip Mali, Manasi Maurya, Samata Bhandari

Journal of Ayurveda and Integrated Medical Sciences · 14.03.2026 · 11 (2) · 14-22

DOI: 10.21760/jaims.11.2.3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ayurveda and Integrated Medical Sciences, online erschienen am 14.03.2026. Verfasst von Dnyaneshwar Bhagwan Mote und 3 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obesity and arthritis are major global health burdens, often coexisting and compounding morbidity through mechanical stress and systemic inflammation. Ayurveda describes Medoroga (obesity) and Sandhivata (arthritis) as conditions responsive to Guggulu (Commiphora wightii), a resin with lipid-lowering and anti-inflammatory properties. This study evaluated Guggulu tablets in adults with obesity and rheumatic disease activity.

Methods

An open-label, single-arm, pre–post clinical trial was conducted at a rheumatology and obesity clinic in Pune, India. Forty participants (mean age 46.8 ± 9.5 years; 65% female; mean BMI 30.0 ± 2.8 kg/m²) with rheumatoid arthritis or osteoarthritis received purified Guggulu tablets (500 mg, twice daily) for 24 weeks. Primary endpoints included changes in body weight, BMI, waist circumference, and disease activity scores (DAS28, WOMAC, pain VAS). Secondary outcomes assessed inflammatory markers, metabolic parameters, lipid profile, and quality of life (HAQ DI).

Results

Thirty-six participants (90%) completed the study. Body weight decreased by −4.3 kg, BMI by −1.6 units, and waist circumference by −5.0 cm (all p

Zitieren

APA

Mote, D. B., Mali, S., Maurya, M., & Bhandari, S. (2026). Efficacy and Safety of Guggulu Tablet in Obesity and Rheumatic Disease Activity: An Open-Label, Single-Arm Clinical Trial. Journal of Ayurveda and Integrated Medical Sciences, 11(2), 14-22. https://doi.org/10.21760/jaims.11.2.3

Vancouver

Mote DB, Mali S, Maurya M, Bhandari S. Efficacy and Safety of Guggulu Tablet in Obesity and Rheumatic Disease Activity: An Open-Label, Single-Arm Clinical Trial. Journal of Ayurveda and Integrated Medical Sciences. 2026;11(2):14-22. doi:10.21760/jaims.11.2.3

BibTeX
@article{Mote2026,
  author = {Mote, Dnyaneshwar Bhagwan and Mali, Sandip and Maurya, Manasi and Bhandari, Samata},
  title = {Efficacy and Safety of Guggulu Tablet in Obesity and Rheumatic Disease Activity: An Open-Label, Single-Arm Clinical Trial},
  journal = {Journal of Ayurveda and Integrated Medical Sciences},
  year = {2026},
  volume = {11},
  number = {2},
  pages = {14--22},
  doi = {10.21760/jaims.11.2.3}
}
Kostenlos starten →